Literature DB >> 8044563

Influence of total colectomy on serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease.

R T Patel1, R Stokes, D Birch, J Ibbotson, M R Keighley.   

Abstract

Perinuclear antineutrophil cytoplasmic antibodies (pANCAs) have previously been demonstrated in patients with various forms of vasculitis and more recently in those with inflammatory bowel disease (IBD) by an indirect immunofluorescence technique. Sera from 194 patients were tested for pANCAs: 101 with ulcerative colitis (43 with varying grades of disease severity, 19 after subtotal colectomy, 39 following restorative proctocolectomy), 40 with Crohn's disease, five with indeterminate colitis, 24 patients without IBD and 24 healthy volunteers (controls). The overall prevalence of pANCAs in patients with ulcerative colitis was 70.3 per cent (71 of 101). These antibodies were still present in 29 of 39 patients after restorative proctocolectomy, in whom the median follow-up after surgery was 2 years. All five patients who had pouchitis after restorative proctocolectomy were pANCA positive. By contrast, only ten of 40 patients with Crohn's disease had pANCAs, nine of whom had Crohn's colitis. No pANCAs were detected in controls. These results show that pANCAs are more prevalent in colonic IBD, especially ulcerative colitis. The persistence of pANCAs in the sera for 2 years after restorative proctocolectomy suggests that the antigens are not fully eradicated and, therefore, that it is not just the colon that is targeted immunologically in ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8044563     DOI: 10.1002/bjs.1800810535

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

1.  Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.

Authors:  E A Vasiliauskas; L Y Kam; L C Karp; J Gaiennie; H Yang; S R Targan
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 2.  Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

Authors:  C Roozendaal; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

3.  Polymorphism of motilin gene in patients with Crohn's disease.

Authors:  V Annese; A Piepoli; A Andriulli; G Napolitano; L Bisceglia; L Zelante; P Gasparini
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

4.  Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitis.

Authors:  M Esteve; J Mallolas; J Klaassen; A Abad-Lacruz; F González-Huix; E Cabré; F Fernández-Bañares; X Bertrán; E Condom; J Martí-Ragué; M A Gassull
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

5.  Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis. A case-control study.

Authors:  J Aisenberg; J Wagreich; J Shim; S Almer; E Peen; T Heimann; I M Gelernt; A Greenstein; P Rubin; N Harpaz
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

6.  Psychobiological subtypes of ulcerative colitis: pANCA status moderates the relationship between disease activity and psychological distress.

Authors:  Robert G Maunder; Gordon R Greenberg; Jonathan J Hunter; William J Lancee; A Hillary Steinhart; Mark S Silverberg
Journal:  Am J Gastroenterol       Date:  2006-10-04       Impact factor: 10.864

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.